Brain MRI: Tumor evaluation

Journal of Magnetic Resonance Imaging

Volumn 24, Issue 4, 2006, Pages 709-724

  Young, Robert J ^a   Knopp, Edmond A ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain; Imaging; Intracranial; MRI; Tumor

Indexed keywords

BRAIN DAMAGE; BRAIN TUMOR; CANCER STAGING; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; IMAGE ANALYSIS; INTRACRANIAL TUMOR; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS;

BRAIN NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 33749604305     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20704     Document Type: Review

References (74)

1. Atlas S, Lavi E, Fisher P. Intraaxial brain tumors. In: Atlas S, editor. Magnetic resonance imaging of the brain and spine. Philadelphia: Lippincott Williams & Wilkins: 2002. p 565-693.
2. Atlas S, Lavi E, Golberg H. Extraaxial brain tumors. In: Atlas S, editor. Magnetic resonance imaging of the brain and spine. Philadelphia: Lippincott Williams & Wilkins; 2002. p 695-772.
3. Grossman R, Yousem D. Neuroradiology: the requisites. In: Thrall J, editor. The requisites. 2nd ed. Philadelphia: Mosby-Elsevier; 2003. p 97-172.
4. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-123.
5. Osborn A, Rauschning W. Brain tumors and tumorlike masses: classification and differential diagnosis. In: AS P, editor. Diagnostic neuroradiology. St. Louis: Mosby-Year Book: 1994. p 401-528.
6. Poussaint TY. Magnetic resonance imaging of pediatric brain tumors: state of the art. Top Magn Reson Imaging 2001;12:411-433.
7. Luh GY, Bird CR. Imaging of brain tumors in the pediatric population. Neuroimaging Clin N Am 1999;9:691-716.
8. Dong Q, Welsh RC, Chenevert TL, et al. Clinical applications of diffusion tensor imaging. J Magn Reson Imaging 2004;19:6-18.
9. Kauppinen RA. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 2002;15:6-17.
10. Castillo M, Mukherji SK. Diffusion-weighted imaging in the evaluation of intracranial lesions. Semin Ultrasound CT MR 2000;21: 405-416.
11. Le Bihan D, Douek P, Argyropoulou M, Turner R, Patronas N, Fulham M. Diffusion and perfusion magnetic resonance imaging in brain tumors. Top Magn Reson Imaging 1993;5:25-31.
12. Chenevert TL, Meyer CR, Moffat BA, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 2002;1:336-343.
13. Law M, Young R, Sasaki T, et al. Comparison of rCBV, vascular permeability, CBF, CBV and MTT measurements using single and two compartment modeling algorithms of data obtained from dynamic susceptibility contrast MRI with glioma grade. In: Proceedings of the 13th Annual Meeting of ISMRM, Miami Beach, FL, USA, 2005. Abstract 368.
14. Wetzel SG, Cha S, Law M, et al. Preoperative assessment of intracranial tumors with perfusion MR and a volumetric interpolated examination: a comparative study with DSA. AJNR Am J Neuroradiol 2002;23:1767-1774.
15. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51.
16. Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiol 1995;36: 520-528.
17. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211: 791-798.
18. Cha S, Knopp EA, Johnson G, et al. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 2000;21:881-890.
19. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715-721.
20. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11-29.
21. Castillo M, Kwock L, Scatliff J, Mukherji SK. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. Magn Reson Imaging Clin N Am 1998;6:1-20.
22. Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 2000;42:333-338.
23. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177:633-641.
24. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686.
25. Castillo M, Kwock L. Proton MR spectroscopy of common brain tumors. Neuroimaging Clin N Am 1998;8:733-752.
26. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 1992;59:55-61.
27. Norfray JF, Tomita T, Byrd SE, Ross BD, Berger PA, Miller RS. Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. AJR Am J Roentgenol 1999;173: 119-125.
28. Lassman AB, DeAngelis LM. Brain metastases. Neurol Clin 2003;21:1-23, vii.
29. Earnest Ft, Kelly PJ, Scheithauer BW, et al. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 1988;166:823-827.
30. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kail BA, Kispert DB. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450-459.
31. Schiffer D. Glioma malignancy and its biological and histological correlates. J Neurosurg Sci 1990;34:163-165.
32. Schiffer D. Pathology of brain tumors and its clinicobiological correlates. Dev Oncol 1991;66:3-9.
33. Pollack IF, Shultz B, Mulvihill JJ. The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 1996;46: 1652-1660.
34. Kleinman G, Zagzag D, Miller D. Diagnostic use of immunohistochemistry in neuropathology. Neurosurg Clin N Am 1994;5:97-126.
35. Fine HA. Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy, and gene therapy. Neurol Clin 1995;13: 827-846.
36. FitzPatrick M, Tartaglino LM, Hollander MD, Zimmerman RA, Flanders AE. Imaging of sellar and parasellar pathology. Radiol Clin North Am 1999;37:101-121.
37. Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab 1999;84:3972-3982.
38. Sartoretti-Schefer S, Wichmann W, Aguzzi A, Valavanis A. MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. AJNR Am J Neuroradiol 1997;18:77-87.
39. Zamani AA. Cerebellopontine angle tumors: role of magnetic resonance imaging. Top Magn Reson Imaging 2000;11:98-107.
40. Choi JY, Chang KH, Yu IK, et al. Intracranial and spinal ependymomas: review of MR images in 61 patients. Korean J Radiol 2002;3:219-228.
41. Packer RJ, Cohen BH, Cooney K. Intracranial germ cell tumors. Oncologist 2000;5:312-320.
42. Koeller KK, Smirniotopoulos JG, Jones RV. Primary central nervous system lymphoma: radiologic-pathologic correlation. Radiographics 1997;17:1497-1526.
43. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11-29.
44. Lamszus K. Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 2004;63:275-286.
45. Sheporaitis LA, Osborn AG, Smimiotopoulos JG, Clunie DA, Howieson J, D'Agostino AN. Intracranial meningioma. AJNR Am J Neuroradiol 1992;13:29-37.
46. Maiuri F, Iaconetta G, de Divitiis O, Cirillo S, Di Salle F, De Caro ML. Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol 1999;31:69-75.
47. Yang S, Law M, Zagzag D, et al. Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. AJNR Am J Neuroradiol 2003;24:1554-1559.
48. Young RJ, Sills AK, Brem S, Knopp EA. Neuroimaging of metastatic brain disease. Neurosurgery 2005;57:310-23: discussion S11-14.
49. Collie D, Brush J, Lammie G, et al. Imaging features of leptomeningeal metastases. Clinical Radiology 1999;54:765-771.
50. Rumana CS, Hess KR, Shi WM, Sawaya R. Metastatic brain tumors with dural extension. J Neurosurg 1998;89:552-558.
51. Yoon PH, Kim DI, Jeon P, Lee SI, Lee SK, Kim SH. Pituitary adenomas: early postoperative MR imaging after transsphenoidal resection. AJNR Am J Neuroradiol 2001;22:1097-1104.
52. Mortini P, Losa M, Barzaghi R, Boari N, Giovanelli M. Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 2005;56:1222-1233; discussion 1233.
53. Erdogan C, Hakyemez B, Yildirim N, Parlak M. Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI. J Comput Assist Tomogr 2005;29:663-667.
54. Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001;22:1109-1116.
55. Byun WM, Kim OL, Kim D. MR imaging findings of Rathke's cleft cysts: significance of intracystic nodules. AJNR Am J Neuroradiol 2000;21:485-488.
56. Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 1987;21:201-206.
57. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989-1998.
58. Akella NS, Twieg DB, Mikkelsen T, et al. Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial. J Magn Reson Imaging 2004;20:913-922.
59. Law M, Oh S, Babb JS, et al. Dynamic susceptibility contrast perfusion MR imaging of low-grade gliomas: cerebral blood volume predicts patient outcome better than histopathology. In: Proceedings of the 13th Annual Meeting of ISMRM, Miami Beach, FL, USA, 2005. Abstract 370.
60. Bertossi M, Virgintino D, Maiorano E, Occhiogrosso M, Roncali L. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol 1997;21:41-49.
61. Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003;24:937-941.
62. Cohen BA, Knopp EA, Rusinek H, Babb JS, Zagzag D, Gonen O. Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy. AJNR Am J Neuroradiol 2005;26:2170-2177.
63. CBTRUS. Statistical report: primary brain tumors in the United States, 1997-2001. Central Brain Tumor Registry of the United States; Hinsdale, IL, 2004.
64. Meyers SP, Kemp SS, Tarr RW. MR imaging features of medulloblastomas. AJR Am J Roentgenol 1992;158:859-865.
65. Osborn A, editor. Meningiomas and other nonglial neoplasms. St. Louis, MO: Mosby: 1994.
66. Zimmerman R, Bilaniuk L, editors. Neuroimaging: clinical and physical principles. New York: Springer-Verlag: 1997.
67. Guillamo JS, Monjour A, Taillandier L, et al. Brainstem gliomas in adults: prognostic factors and classification. Brain 2001;124:2528-2539.
68. Walker DA, Punt JA, Sokal M. Clinical management of brain stem glioma. Arch Dis Child 1999;80:558-564.
69. Levy ML, Goldfarb A, Hyder DJ, et al. Choroid plexus tumors in children: significance of stromal invasion. Neurosurgery 2001;48: 303-309.
70. Urso JA, Ross GJ, Parker RK, Patrizi JD, Stewart B. Colloid cyst of the third ventricle: radiologic-pathologic correlation. J Comput Assist Tomogr 1998;22:524-527.
71. Park SH, Ostrzega N, Akers MA, Vinters HV. Intraventricular neurocytoma with prominent myelin figures. Ultrastruct Pathol 1999;23:311-317.
72. Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 1999;66: 370-375.
73. Deshmukh VR, Smith KA, Rekate HL, Coons S, Spetzler RF. Diagnosis and management of pineocytomas. Neurosurgery 2004;55: 349-355; discussion 355-347.
74. Friedman JA, Lynch JJ, Buckner JC, Scheithauer BW, Raffel C. Management of malignant pineal GCT with residual mature teratoma. Neurosurgery 2001;48:518-522; discussion 522-513.